These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 672427)

  • 21. Effect of discrete kainic acid-induced lesions of corpus caudatus and globus pallidus on glutamic acid decarboxylase of rat substantia nigra.
    Di Chiara G; Morelli M; Porceddu ML; Mulas M; Del Fiacco M
    Brain Res; 1980 May; 189(1):193-208. PubMed ID: 7363085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients.
    Lloyd KG; Möhler H; Heitz P; Bartholini G
    J Neurochem; 1975 Dec; 25(6):789-95. PubMed ID: 1206397
    [No Abstract]   [Full Text] [Related]  

  • 23. Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration.
    Marshall EF; Perry RH; Perry EK; Piggott MA; Thompson P; Jaros E; Burn DJ
    Acta Neurol Scand; 1997 May; 95(5):287-92. PubMed ID: 9188904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergic system in monkeys.
    Apicella P; Trouche E; Nieoullon A; Legallet E; Dusticier N
    Neuroscience; 1990; 38(3):655-66. PubMed ID: 2125332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-glutamate decarboxylase and choline acetyltransferase activity in the substantia nigra and the striatum after surgical interruption of the strio-nigral fibres of the baboon.
    Kataoka K; Bak IJ; Hassler R; Kim JS; Wagner A
    Exp Brain Res; 1974 Jan; 19(2):217-27. PubMed ID: 4205642
    [No Abstract]   [Full Text] [Related]  

  • 26. Subcellular fractions of normal human substantia nigra and caudate nucleus; a study of their morphology and some enzymes including glutamate decarboxylase and choline acetyltransferase.
    Hickey SM; Ansell GB; Mitchell K; Pearce GW
    J Neurochem; 1976 Oct; 27(4):957-62. PubMed ID: 966028
    [No Abstract]   [Full Text] [Related]  

  • 27. Substance-P pathways in rat brain.
    Emson PC; Kanazawa I; Cuello AC; Jessell TM
    Biochem Soc Trans; 1977; 5(1):187-9. PubMed ID: 892157
    [No Abstract]   [Full Text] [Related]  

  • 28. The diurnal variations of glutamic acid decarboxylase activity in some discrete nuclei of rat brain.
    Kawahara R; Hazama H; Kamase H; Takeshita H; Kunimoto N; Kayano M
    Folia Psychiatr Neurol Jpn; 1980; 34(4):473-9. PubMed ID: 7196368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of glutamic acid decarboxylase in the proximal parts of presumed GABA-ergic neurones after axotomy.
    Storm-Mathisen J
    Brain Res; 1975 Apr; 87(1):107-9. PubMed ID: 235348
    [No Abstract]   [Full Text] [Related]  

  • 30. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
    Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
    Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pallido-subthalamic projection in rat: anatomical and biochemical studies.
    van der Kooy D; Hattori T; Shannak K; Hornykiewicz O
    Brain Res; 1981 Jan; 204(2):253-68. PubMed ID: 7459631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: properties and localization in dopaminergic neurons.
    Lehmann J; Fibiger HC
    J Neurochem; 1978 Mar; 30(3):615-24. PubMed ID: 681936
    [No Abstract]   [Full Text] [Related]  

  • 34. Mosaic distribution of phosphate-activated glutaminase-like immunoreactivity in the rat striatum.
    Kaneko T; Mizuno N
    Neuroscience; 1992 Jul; 49(2):329-45. PubMed ID: 1436471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of prolactin in sulpiride-induced changes in nigral and striatal GAD activity.
    Scapagnini U; Canonico PL; Patti F; Condorelli DF; Nicoletti F
    Ann Ist Super Sanita; 1982; 18(1):27-9. PubMed ID: 7171172
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.
    McGeer PL; McGeer EG; Wada JA; Jung E
    Brain Res; 1971 Sep; 32(2):425-31. PubMed ID: 4944072
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.
    Perry EK; Gibson PH; Blessed G; Perry RH; Tomlinson BE
    J Neurol Sci; 1977 Nov; 34(2):247-65. PubMed ID: 144789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection.
    Nitsch C; Riesenberg R
    Brain Res; 1988 Sep; 461(1):127-42. PubMed ID: 3224272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tremor and motility following oxotremorine and harmine in rats with lesions of the nigro-striatal system].
    Westermann KH; Oelszner W; Staib AH; Funk K
    Acta Biol Med Ger; 1974; 33(1):67-76. PubMed ID: 4153886
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurotransmitter synthesizing enzymes in experimental viral encephalitis.
    Elizan TS; Maker H; Yahr MD
    J Neural Transm; 1983; 57(3):139-47. PubMed ID: 6139411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.